Literature DB >> 27888140

Designed covalent allosteric modulators: an emerging paradigm in drug discovery.

Shaoyong Lu1, Jian Zhang2.   

Abstract

Covalent allosteric modulators possess the pharmacological advantages (high potency, extended duration of action and low drug resistance) of covalent ligands and the additional benefit of the higher specificity and lower toxicity of allosteric modulators. This approach is gaining increasing recognition as a valuable tool in drug discovery. Here, we review the recent advances in the design of covalent allosteric modulators with an emphasis on successful examples. A broad spectrum of protein targets capable of being modulated by them reflects the prevalence of this strategy. We also discuss the challenges and future directions in the development of covalent allosteric modulators.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27888140     DOI: 10.1016/j.drudis.2016.11.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

1.  Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders.

Authors:  Simone Brogi; Giuseppe Campiani; Margherita Brindisi; Stefania Butini
Journal:  ACS Med Chem Lett       Date:  2019-01-23       Impact factor: 4.345

Review 2.  The Taxonomy of Covalent Inhibitors.

Authors:  Alfred Tuley; Walter Fast
Journal:  Biochemistry       Date:  2018-04-30       Impact factor: 3.162

Review 3.  Engineered control of enzyme structural dynamics and function.

Authors:  David D Boehr; Rebecca N D'Amico; Kathleen F O'Rourke
Journal:  Protein Sci       Date:  2018-02-16       Impact factor: 6.725

4.  Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B.

Authors:  Chang Liu; Zhizhen Li; Zonghan Liu; Shiye Yang; Qing Wang; Zongtao Chai
Journal:  Front Mol Biosci       Date:  2022-05-10

5.  Computational Insights into the Interactions between Calmodulin and the c/nSH2 Domains of p85α Regulatory Subunit of PI3Kα: Implication for PI3Kα Activation by Calmodulin.

Authors:  Duan Ni; Dingyu Liu; Jian Zhang; Shaoyong Lu
Journal:  Int J Mol Sci       Date:  2018-01-04       Impact factor: 5.923

Review 6.  The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1.

Authors:  Xinyuan Xu; Yingyi Chen; Qiang Fu; Duan Ni; Jian Zhang; Xiaolong Li; Shaoyong Lu
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

7.  Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization.

Authors:  Maarten L J Doornbos; Xuesong Wang; Sophie C Vermond; Luc Peeters; Laura Pérez-Benito; Andrés A Trabanco; Hilde Lavreysen; José María Cid; Laura H Heitman; Gary Tresadern; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2018-03-07       Impact factor: 7.446

Review 8.  The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.

Authors:  Attila Egyed; Dóra Judit Kiss; György M Keserű
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

9.  Molecular Dynamics Simulations and Dynamic Network Analysis Reveal the Allosteric Unbinding of Monobody to H-Ras Triggered by R135K Mutation.

Authors:  Duan Ni; Kun Song; Jian Zhang; Shaoyong Lu
Journal:  Int J Mol Sci       Date:  2017-10-26       Impact factor: 5.923

Review 10.  Does Ras Activate Raf and PI3K Allosterically?

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.